Four rapid, smart, and easy to apply spectrophotometric methods were displayed for the estimation of Solifenacin succinate (SOL) in existence of its acid inspired degradation product. Development of stability indicating smart, sensitive, cheap spectrophotometric methods for determination of SOL in presence of its acid degradate. (Method A) is dual wavelength (DW) method; where, two wavelengths were selected; 262 and 289 nm were utilized to determine SOL in existence of its acid degradate. (Method B) is developing the first derivative (1D) of the absorption spectra. Peak signal was detected at 276 nm. (Method C) is ratio difference (RD) method where the drug is determined by the difference in signal between two selected wavelengths, at 240 and 259 nm. (Method D) depended on measuring peak signal of the first derivative of the ratio spectra (1DD) at 269 nm. Calibration curves of the suggested methods exhibited linearity. The selectivity of the suggested methods were ascertained using different laboratory prepared mixtures of SOL with its acid degradate indicating specificity of SOL with accepted recovery values. The suggested methods have been successfully applied to the analysis of SOL in its pharmaceutical dosage form without involvement of additives. The presented work applied four resolution techniques, based on absorbance, derivative and/or ratio spectra, for the analysis of SOL in the existence of its acid degradate. Study of degradation pathway of drugs is of great importance nowadays. Hence, acid hydrolysis of SOL was achieved and then SOL determined along with its acid degradate.
Background: The bupivacaine (BVC)/meloxicam (MLX) combination is the first extended-release dual-acting local anesthetic (DALA) that provides 72 h of postoperative pain relief. It reduces opioid use after surgery and manages pain better than BVC alone over 72 h, and overcomes surgical site inflammation with a new synergistic mode of action that combines BVC with a low dosage of MLX. Objective: In today's pharmaceutical research, we take great care to only use non-toxic solvents that pose no threat to either humans or the environment. This work determines BVC and MLX simultaneously, utilizing water and 0.1 M HCl in water as solvents. Moreover, the eco-friendliness of the specified solvents and the whole method development steps was evaluated based on how user-friendly they were using four standard methodologies. Methods: The developed spectrophotometric methods depended on either zero-order, derivative, or ratio spectra that only required simple mathematical handling. The current techniques include dual wavelength (DW), Fourier self-deconvolution (FSD), first derivative (D1), ratio difference (RD), and first ratio derivative (DD1). Results: Linearity was confirmed over a concentration range of 50–700 μg/mL for BVC and 1–10 μg/mL for MLX. For BVC and MLX, the LOQs were 26.85–41.33 μg/mL and 0.21–0.95 μg/mL, while the LODs were 8.86–13.64 μg/mL and 0.06–0.31 μg/mL, respectively. For the full validation of the proposed methods, ICH (international conference on harmonization) criteria were followed. Conclusion: Current methods have the advantage of sticking to the basis of zero-order, derivative, or ratio spectra and needing just the barest minimum of data processing: no complex software, lengthy stages, or transformations are needed. Highlights: No spectrophotometric methods have been published for the simultaneous analysis of BVC and MLX. As a result, the newly developed spectrophotometric approaches have great relevance and originality in the field of pharmaceutical analysis.
Background: Gliflozins and gliptins are two distinct groups of pharmacological drugs that reduce blood glucose levels in individuals with type II diabetes in various ways that may perform their functions harmoniously. Trijardy® tablet, which contains empagliflozin, linagliptin, and metformin, was recently approved. The scientific database does not yet have a method that is sensitive enough to quantify the aforementioned medications in the presence of metformin official toxic impurities melamine and cyanoguanidine. Molecular docking modeling was utilized in this work to further prove the toxicity of melamine. Methods: The five analytes listed before were quantified using RP-HPLC-diode array detector and a Zorbax® C8 column (4.6 × 250 mm, 5 μm) with isocratic mobile phase composed of acetonitrile and 0.05 M potassium dihydrogen phosphate buffer, which had been treated by ?-phosphoric acid to restore a pH of 4.0 (90:10, v/v) at a flow rate of 1.2 mL/min and the eluted peaks were scanned at 250 nm. Conclusion: The utilization of the simplest isocratic elution mode give the current technique a significant time-and cost-saving benefit. The current method can quantify the triple therapy agents in the presence of each other as well as with two official toxic impurities of metformin in one short analytical run.